Clinical trials
Phase 2 Uterine Cervical Neoplasms trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Belgian Gynaecological Oncology Group | 2 |
| Daiichi Sankyo | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| GlaxoSmithKline | 1 |
| Hoffmann-La Roche | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Nykode Therapeutics ASA | 1 |
| Regeneron Pharmaceuticals | 1 |
| Seagen Inc. | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 13 |
| Endometrial Neoplasms | 4 |
| Ovarian Neoplasms | 3 |
| Recurrence | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Uterine Neoplasms | 2 |
| Adenocarcinoma | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.